The immunotherapy field is advancing rapidly. Within immuno-oncology, therapeutic and diagnostic antibodies are joined by T cells engineered with receptors that recognize tumors, and checkpoints preventing target recognition are being overridden.
Flow cytometry has long been the workhorse of immunology. Yet traditional flow cytometry can be a laborious and time-consuming process, offering low-throughput acquisition. I-O drug discovery, development, and manufacturing quality control all benefit from an easy-to-use, high-throughput, multiplex platform that uses minimal sample volumes, to query cells for phenotype, health and proliferation, as well as protein (cytokine) production.
This eBook looks at examples of how an advanced flow cytometry platform, along with associated reagent kits, allows for faster, easier, more efficient assays and analysis, from microwell plates, removing the data analysis bottleneck inherent in traditional flow cytometry.